Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kao-Tai Tsai

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Journal of Biopharmaceutical Statistics|February 13, 2009
Multivariate dose response testKao-Tai Tsai, Karl E Peace
Journal of Biopharmaceutical Statistics|February 13, 2009
Bivariate or composite plots of endpointsKarl E Peace, Kao-Tai Tsai
Anti-Cancer Drugs|August 2, 2007
A phase II study of irinotecan, high-dose 24-h continuous intravenous infusion of floxuridine and leucovorin (IFLUX) for advanced, previously untreated colorectal cancerBach Ardalan, Olga Kozyreva, Kao-Tai Tsai, et al.
Cancer Chemotherapy and Pharmacology|February 10, 2020
Evaluation of the bioequivalence and food effect on the bioavailability of CC-486 (oral azacitidine) tablets in adult patients with cancerHani M Babiker, Mohammed Milhem, Joseph Aisner, et al.
Cancer Chemotherapy and Pharmacology|March 28, 2020
Correction to: Evaluation of the bioequivalence and food effect on the bioavailability of CC-486 (oral azacitidine) tablets in adult patients with cancerHani M Babiker, Mohammed Milhem, Joseph Aisner, et al.
British Journal of Haematology|March 29, 2023
Oral azacitidine modulates the bone marrow microenvironment in patients with acute myeloid leukaemia in remission: A subanalysis from the QUAZAR AML-001 trialDaniel L Menezes, Wendy L See, Alberto Risueño, et al.
Blood|January 14, 2021
Multiple cereblon genetic changes are associated with acquired resistance to lenalidomide or pomalidomide in multiple myelomaSarah Gooding, Naser Ansari-Pour, Fadi Towfic, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Journal of Biopharmaceutical Statistics|February 13, 2009
Multivariate dose response testKao-Tai Tsai, Karl E Peace
Journal of Biopharmaceutical Statistics|February 13, 2009
Bivariate or composite plots of endpointsKarl E Peace, Kao-Tai Tsai
Anti-Cancer Drugs|August 2, 2007
A phase II study of irinotecan, high-dose 24-h continuous intravenous infusion of floxuridine and leucovorin (IFLUX) for advanced, previously untreated colorectal cancerBach Ardalan, Olga Kozyreva, Kao-Tai Tsai, et al.
Cancer Chemotherapy and Pharmacology|February 10, 2020
Evaluation of the bioequivalence and food effect on the bioavailability of CC-486 (oral azacitidine) tablets in adult patients with cancerHani M Babiker, Mohammed Milhem, Joseph Aisner, et al.
Cancer Chemotherapy and Pharmacology|March 28, 2020
Correction to: Evaluation of the bioequivalence and food effect on the bioavailability of CC-486 (oral azacitidine) tablets in adult patients with cancerHani M Babiker, Mohammed Milhem, Joseph Aisner, et al.
British Journal of Haematology|March 29, 2023
Oral azacitidine modulates the bone marrow microenvironment in patients with acute myeloid leukaemia in remission: A subanalysis from the QUAZAR AML-001 trialDaniel L Menezes, Wendy L See, Alberto Risueño, et al.
Blood|January 14, 2021
Multiple cereblon genetic changes are associated with acquired resistance to lenalidomide or pomalidomide in multiple myelomaSarah Gooding, Naser Ansari-Pour, Fadi Towfic, et al.
Pageof 1